A conversation with Alex Butler, Digital Strategy and Social Media Manager at Janssen, and Silja Chouquet, Founder and Chief Executive Officer, Whydot Pharma (See guest bios), about SMi's 2011 conference on Social Media in the Pharmaceutical Industry taking place in Central London with a focus on the larger issue of whether the "social media" distinction is losing its meaning in a world where most of what's of value on the Internet is social.
This show and ALL Pharma Marketing Talk shows are available as podcasts via PMT on iTunes (FREE!).
SMi's 2011 conference on Social Media in the Pharmaceutical Industry aims to address the current concerns of the industry about using social media, while allowing delegates to explore the best methods for entering this interactive environment and using it successfully to reach your goals.
There are many social media platforms to choose from, many ways of interacting and many uses for social media in the pharma industry - marketing, corporate communications, brand development, product recognition, interacting with patient groups and more. Through explanatory talks and relevant case studies, delegates will leave the conference with a knowledge and confidence that will allow them to introduce successful social media strategies into their organisations.
Taking place in London, UK, this conference will also cover social media monitoring and social networking software to ensure delegates can maximise their use of social media marketing, communications and patient group interaction.
Recently Alex Butler wrote a piece in Pharma Times questioning whether social media exists anymore (see resources for a link to the article). "We live in a post-advertising age where messages no longer resonate without dialogue, and where information is best exchanged through community," said Butler. "But although it is tempting to think that contact is now king, in fact high value dynamic content, valued by the consumer, has never been more important...there is little of value on the internet that is not socialised in some form, even if it is just the capacity to comment and share. So how as an industry can we influence the exchange of ideas and information if we are not prepared to be where our audience and communities exist?"
Please give us a synopsis of what will be covered during this conference.
Tell us specifically about the presentations you will make.
What do you think of Alex's comments regarding the value of social media?
Alex Butler, Digital Strategy and Social Media Manager, Janssen Cilag, has worked in the pharmaceutical industry for over ten years across the breadth of the business including Market Access, Marketing and Communications. He has a passion for new media and developed an award winning fully digital integrated campaign as Product Manager, the first fully paper free campaign in Janssen-Cilag. His expertise in social media and strategic planning has led into a new role in Corporate Communications. As Communications Manager Alex is leading corporate social media and online media relations through a number community and patient support projects. This includes being the first UK based pharmaceutical company to have an active twitter account and the development of the first virtual newsroom in UK pharma. Alex is the first recipient of the coveted Pharmaguy Social Media Pioneer Award.
Silja Chouquet, Founder and Chief Executive Officer, Whydot GmbH, is the owner and CEO of whydot GmbH, an agency specialized in social media consulting, coaching and training. Her fields of expertise are the creation of patient-focused social media communications and marketing campaigns. Prior to starting her own business, Silja built a solid track record as a consultant and line manager in the health care industry with over ten years of experience. She worked for major pharmaceutical companies, where she held senior positions in sales, strategic planning, market research and business intelligence. Silja is the co-founder of hcsmeu, a weekly conversation on twitter about the state of healthcare and social media in Europe. She also writes industry commentary on her blog whydotpharma, which focuses on how pharma can use social media to become more patient-focused. Silja started her career as a senior consultant at Mercer Management (now Oliver Wyman). She holds a BS in International Business and Marketing from Georgetown University in Washington DC and an MBA from INSEAD. Silja speaks German, English and French.